0001104659-22-110922.txt : 20221024
0001104659-22-110922.hdr.sgml : 20221024
20221024160932
ACCESSION NUMBER: 0001104659-22-110922
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221020
FILED AS OF DATE: 20221024
DATE AS OF CHANGE: 20221024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kapur Anil
CENTRAL INDEX KEY: 0001730703
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35403
FILM NUMBER: 221326164
MAIL ADDRESS:
STREET 1: 275 MADISON AVE
STREET 2: SUITE 702
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verastem, Inc.
CENTRAL INDEX KEY: 0001526119
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273269467
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: (781) 292-4200
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
4
1
tm2228716-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-10-20
0
0001526119
Verastem, Inc.
VSTM
0001730703
Kapur Anil
C/O VERASTEM, INC., 117 KENDRICK ST.,
SUITE 500
NEEDHAM
MA
02494
1
0
0
0
Stock Option (right to buy)
0.30
2022-10-20
4
A
0
163185
0
A
2032-10-20
Common Stock
163185
163185
D
-125,000 of the stock options vest in twelve equal quarterly installments beginning each three successive month period following October 20, 2022 (the "Option Grant Date") until the third anniversary of the Option Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest). 38,185 of the stock options vest in eight equal month installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest) beginning on the on the last day of each month over a period from October, 2022 to May, 2023. The options vest provided the Reporting Person continues to serve as a director of the Issuer on each such vesting date.
/s/ Robert E. Gagnon, Attorney-in-Factor
2022-10-24